Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.00 -0.24 (-1.29%)
As of: Sep 30, 2026 · 10:25 AM EDT

Syndax Pharmaceuticals (SNDX) EV to EBIT (2021 - 2022)

Updated

Syndax Pharmaceuticals' EV to EBIT came in at 632.80 for Q2 2022.

Analysis

Syndax Pharmaceuticals (SNDX) EV to EBIT (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Jun 30, 2022, Syndax Pharmaceuticals reported EV to EBIT of -308.11; for FY2021, it came in at 29.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Syndax Pharmaceuticals 1.59 Bn -137.74 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 632.80
Mar 31, 2022 33.79
Dec 31, 2021 29.12
API Access

Syndax Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SNDX&period=max&api_key=YOUR_API_KEY